Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients

NCT00294866 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure

Interventions

DRUG: Paricalcitol

Sponsor

Fresenius Medical Care North America

Collaborators

[object Object]